샘플 요청 목록

 카트 문의
시장보고서
상품코드
1655298

세계의 마이코플라스마 검사 시장

Mycoplasma Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 158 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

마이코플라스마 검사 세계 시장은 2030년까지 19억 달러에 달할 전망

2024년에 11억 달러로 추정되는 마이코플라스마 검사 세계 시장은 2030년에는 19억 달러에 달하고, 분석기간인 2024-2030년 CAGR은 8.6%로 성장할 것으로 예측됩니다. 마이코플라스마 검사 어세이, 키트, 시약은 이 보고서에서 분석한 부문 하나이며, 분석기간 종료까지 CAGR 9.4%를 기록하며 9억 4,080만 달러에 달할 것으로 예측됩니다. 마이코플라스마 검사 서비스 분야의 성장률은 분석기간 동안 CAGR 8.1%로 추정됩니다.

미국 시장은 2억 9,190만 달러로 추정, 중국은 CAGR 12.7%로 성장 예측

미국의 마이코플라스마 검사 시장은 2024년에 2억 9,190만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석기간인 2024-2030년 CAGR 12.7%로 2030년까지 4억 8,320만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석기간 동안 CAGR은 각각 4.4%와 7.7%로 예측됩니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 것으로 예측됩니다.

세계 마이코플라스마 검사 시장 동향 및 촉진요인 정리

마이코플라스마 검사란 무엇이며, 왜 바이오의약품과 세포배양에 필수적인가?

마이코플라스마 검사는 세포배양, 바이오의약품, 백신에서 마이코플라스마 오염을 검출하는 것을 말합니다. 마이코플라스마는 세포벽이 없는 박테리아의 일종으로, 바이오의약품 제조에 사용되는 세포배양에서 오염을 일으킬 수 있습니다. 그 크기와 유연성으로 인해 기존의 필터를 통과하여 감지되지 않고 생명공학 공정을 오염시켜 제품의 안전성과 효능을 손상시킬 수 있습니다. 마이코플라스마 오염은 세포 생리학의 변화, 부정확한 실험 결과, 제품 회수로 이어질 수 있기 때문에 실험실, 제약 회사, 바이오의약품 제조 시설에서는 일상적인 검사가 필수적입니다. 마이코플라스마 검사는 규제 기준을 준수하고 의료 및 연구에 사용되는 세포 유래 제품의 무결성을 유지하기 위해 필수적입니다.

기술의 발전은 마이코플라스마 검사 방법을 어떻게 형성하고 있는가?

기술 혁신은 마이코플라스마 검사의 정확성, 속도 및 신뢰성을 크게 향상시키고 있습니다. 전통적으로 마이코플라스마 검출은 배양에 기반한 방법으로 이루어지며, 이는 시간과 노력이 많이 소요되고 결과가 나오기까지 몇 주가 걸립니다. 그러나 중합효소 연쇄 반응(PCR) 및 실시간 PCR(qPCR)과 같은 분자진단학의 발전은 보다 신속하고 민감하며 특이적인 오염 검출을 가능하게 하여 마이코플라스마 검사에 혁명을 일으켰습니다. 또한, 핵산 증폭 기술(NAATs)과 차세대 염기서열 분석(NGS) 기술은 검출 능력을 더욱 향상시켜 보다 광범위한 마이코플라스마 종을 식별할 수 있게 해줍니다. 자동화된 검사 플랫폼은 일상적인 검사에 필요한 시간과 노동력을 줄이고, 실험실과 생산시설이 실시간으로 오염 없는 환경을 보장할 수 있도록 돕습니다.

규제 요건과 업계 표준은 마이코플라스마 검사 수요에 어떤 영향을 미치고 있는가?

바이오의약품 제조에 대한 엄격한 규제 요건과 안전하고 효과적인 생명공학 제품에 대한 수요가 증가함에 따라 마이코플라스마 검사에 대한 수요가 증가하고 있습니다. 미국 식품의약국(FDA) 및 유럽의약품청(EMA)과 같은 규제 기관은 제품의 안전성을 보장하고 오염을 방지하기 위해 세포 기반 제품, 생물학적 제제 및 백신에 대한 일상적인 마이코플라스마 검사를 의무화하고 있습니다. 이러한 규정을 준수하는 것은 제약회사가 제품 승인을 유지하고 비용이 많이 드는 지연과 리콜을 피하기 위해 필수적입니다. 바이오의약품 산업의 성장과 CRO(임상시험수탁기관) 및 CMO(의약품 제조수탁기관)의 확대는 보다 신속하고 신뢰할 수 있는 조사 방법의 채택을 촉진하고 있습니다. 또한, 오염 위험이 제품의 생존율에 큰 영향을 미칠 수 있는 세포 치료제 및 유전자 치료제의 증가로 인해 엄격한 시험 프로토콜의 필요성이 더욱 커지고 있습니다.

마이코플라스마 검사 시장의 주요 성장 촉진요인은 무엇인가?

마이코플라스마 검사 시장의 성장은 분자진단의 발전, 규제 당국의 감시 강화, 바이오의약품 생산 확대 등 여러 요인에 의해 이루어지고 있으며, PCR 및 NGS와 같은 보다 신속하고 정밀한 검사법으로의 전환은 오염 검출을 강화하여 이러한 기술을 업계에서 점점 더 널리 보급하고 있습니다. 생물학적 제제, 백신 및 세포 기반 치료법의 확산은 이러한 제품들이 특히 오염의 영향을 받기 쉽기 때문에 신뢰할 수 있는 마이코플라스마 검사에 대한 수요 증가에 기여하고 있습니다. 또한, 생물학적 제제 및 세포배양에 대한 정기적인 검사를 의무화하는 규제 요건은 고급 마이코플라스마 검출 솔루션의 채택을 더욱 촉진하고 있습니다. 제약 업계에서는 규정 준수와 제품 안전성을 보장하기 위해 견고한 검사 프로토콜이 필요하기 때문에 위탁 연구 및 제조 서비스 이용이 증가하고 있는 것도 촉진요인이 되고 있습니다. 마지막으로, 생명공학 공정에서 품질 관리에 대한 관심이 높아지면서 보다 효율적이고 자동화된 검사 플랫폼의 지속적인 개발이 촉진되어 시장 성장을 더욱 가속화하고 있습니다.

부문

제공(분석, 키트 및 시약, 서비스, 장비), 기법(핵산검사(NAT), ELISA, 염색, 기타 기법), 응용(세포주 검사, 생산 종료 세포 검사, 바이러스 검사, 기타 응용)

조사 대상 기업 예시(11개사)

  • American Type Culture Collection(ATCC)
  • Biological Industries Israel Beit Haemek Ltd.
  • Biounique Testing Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Invivogen
  • Lonza Group AG
  • Merck KgaA
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Roche Diagnostics(Schweiz) AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec Co., Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.03.14

Global Mycoplasma Testing Market to Reach US$1.9 Billion by 2030

The global market for Mycoplasma Testing estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million by the end of the analysis period. Growth in the Mycoplasma Testing Services segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$291.9 Million While China is Forecast to Grow at 12.7% CAGR

The Mycoplasma Testing market in the U.S. is estimated at US$291.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$483.2 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Mycoplasma Testing Market – Key Trends & Drivers Summarized

What Is Mycoplasma Testing and Why Is It Essential in Biopharmaceuticals and Cell Cultures?

Mycoplasma testing refers to the detection of mycoplasma contamination in cell cultures, biopharmaceutical products, and vaccines. Mycoplasmas are a group of bacteria that lack a cell wall and can cause contamination in cell cultures used in biopharmaceutical production. Due to their small size and flexibility, they can pass through conventional filters and contaminate biotechnological processes without detection, compromising product safety and efficacy. Mycoplasma contamination can lead to alterations in cell physiology, inaccurate experimental results, and product recalls, making routine testing essential in laboratories, pharmaceutical companies, and biopharmaceutical production facilities. Testing for mycoplasma is critical for ensuring compliance with regulatory standards and maintaining the integrity of cell-based products used in medical treatments and research.

How Are Technological Advances Shaping Mycoplasma Testing Methods?

Technological innovations are significantly improving the accuracy, speed, and reliability of mycoplasma testing. Traditionally, mycoplasma detection was performed using culture-based methods, which are time-consuming and labor-intensive, taking weeks to yield results. However, advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and real-time PCR (qPCR), have revolutionized mycoplasma testing by enabling faster, more sensitive, and specific detection of contamination. Additionally, nucleic acid amplification techniques (NAATs) and next-generation sequencing (NGS) technologies are further enhancing detection capabilities, allowing for the identification of a broader range of mycoplasma species. Automated testing platforms are also reducing the time and labor required for routine testing, making it easier for laboratories and production facilities to ensure contamination-free environments in real-time.

How Are Regulatory Requirements and Industry Standards Impacting the Demand for Mycoplasma Testing?

Stringent regulatory requirements in biopharmaceutical production and the increasing demand for safe and effective biotechnological products are driving the demand for mycoplasma testing. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) mandate routine mycoplasma testing for cell-based products, biologics, and vaccines to ensure product safety and prevent contamination. Compliance with these regulations is critical for pharmaceutical companies to maintain product approval and avoid costly delays or recalls. The growing biopharmaceutical industry, along with the expansion of contract research organizations (CROs) and contract manufacturing organizations (CMOs), is also pushing the adoption of faster and more reliable mycoplasma testing methods. Moreover, with the rise in cell and gene therapies, where contamination risks can significantly affect product viability, the need for stringent testing protocols has become even more essential.

What Are the Key Growth Drivers in the Mycoplasma Testing Market?

The growth in the mycoplasma testing market is driven by several factors, including advancements in molecular diagnostics, increased regulatory scrutiny, and the expansion of biopharmaceutical production. The shift toward faster and more precise testing methods, such as PCR and NGS, is enhancing contamination detection, making these technologies increasingly popular in the industry. The rising prevalence of biologics, vaccines, and cell-based therapies is also contributing to the growing demand for reliable mycoplasma testing, as these products are particularly susceptible to contamination. Additionally, regulatory requirements mandating regular testing of biologics and cell cultures are further pushing the adoption of advanced mycoplasma detection solutions. The growing use of contract research and manufacturing services in the pharmaceutical industry is another driver, as these organizations require robust testing protocols to ensure compliance and product safety. Lastly, the increasing focus on quality control in biotechnological processes is promoting the continuous development of more efficient and automated testing platforms, further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Mycoplasma Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Assays, Kits & Reagents, Services, Instruments); Technique (Nucleic Acid Testing (NAT), ELISA, Staining, Other Techniques); Application (Cell Line Testing, End-of-Production Cell Testing, Virus Testing, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • American Type Culture Collection (ATCC)
  • Biological Industries Israel Beit Haemek Ltd.
  • Biounique Testing Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Invivogen
  • Lonza Group AG
  • Merck KgaA
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Roche Diagnostics (Schweiz) AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Mycoplasma Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Adoption of Biopharmaceuticals Spurs Demand for Mycoplasma Testing in Manufacturing
    • Increasing Regulatory Scrutiny Expands Addressable Market for Mycoplasma Testing in Drug Development
    • Technological Advancements in PCR-Based Testing Strengthen Business Case for Rapid Mycoplasma Detection
    • Growth in Cell Culture-Based Research Drives Adoption of Routine Mycoplasma Testing in Laboratories
    • Increasing Use of Mycoplasma Testing in Gene and Cell Therapies Expands Market for Advanced Testing Solutions
    • Rising Focus on Contamination Control in Biomanufacturing Propels Growth in Mycoplasma Testing Services
    • Expansion of Contract Research Organizations (CROs) Fuels Demand for Outsourced Mycoplasma Testing
    • Increasing Investment in Vaccine Development Strengthens Market for Mycoplasma Testing in Biopharma R&D
    • Expansion of Stem Cell Research and Regenerative Medicine Spurs Demand for Mycoplasma Testing in Cell Cultures
    • Technological Innovations in Digital PCR Propel Growth in Sensitivity and Speed of Mycoplasma Detection
    • Rising Demand for Mycoplasma-Free Biological Products Drives Adoption of Testing Protocols in Drug Development
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mycoplasma Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mycoplasma Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Assays, Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Assays, Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Assays, Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Nucleic Acid Testing (NAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Nucleic Acid Testing (NAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Nucleic Acid Testing (NAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Staining by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cell Line Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cell Line Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cell Line Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for End-of-Production Cell Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for End-of-Production Cell Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for End-of-Production Cell Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mycoplasma Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mycoplasma Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mycoplasma Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mycoplasma Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제